Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA

OBJECTIVES: The aim was to evaluate retention rates for secukinumab in patients with active PsA or radiographic axial spondyloarthritis (r-axSpA) treated in routine UK clinical practice. METHODS: SERENA (CAIN457A3403) is an ongoing, non-interventional, international study of patients with moderate-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaffney, Karl, Gullick, Nicola, MacKay, Kirsten, Patel, Yusuf, Sengupta, Raj, Sheeran, Tom, Hemmings, Louise, Pamies, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472087/
https://www.ncbi.nlm.nih.gov/pubmed/37663578
http://dx.doi.org/10.1093/rap/rkad055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472087/
https://www.ncbi.nlm.nih.gov/pubmed/37663578
http://dx.doi.org/10.1093/rap/rkad055

Ejemplares similares